For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20260514:nRSN4243Ea&default-theme=true
RNS Number : 4243E Itaconix PLC 14 May 2026
For immediate release
ITACONIX PLC
("Itaconix" or the "Company")
Adjournment of Annual General Meeting
Itaconix plc (AIM: ITX) (OTCQB: ITXXF), a leading innovator in
high-performance plant-based specialty polymers, announces that the Annual
General Meeting ("AGM"), originally scheduled for earlier today, Thursday 14
May 2026, has been adjourned to 14:00 BST on 10 June 2026 at Fieldfisher LLP,
9th Floor, Riverbank House, 2 Swan Lane, London EC4R 3TT, United Kingdom.
Accordingly, no business was conducted and none of the resolutions were
considered.
Shareholders are referred to the Notes attached to the Notice of General
Meeting, which is available on the Company's website (www.itaconix.com) and
which were posted to shareholders on 24 March 2026, with regards to revoking
an existing and / or submitting a new proxy appointment.
On that basis, the new deadline for submission of proxy appointments to the
Company's registrar will be 14:00 BST on 8 June 2026. Proxy appointments
already submitted will remain valid for the adjourned General Meeting unless
revoked or superseded by a new proxy.
- Ends -
Itaconix plc +1 603 775-4400
John R. Shaw / Laura Denner
Rosewood +44 (0)20 7653 8702
John West / Llewellyn Angus / Lily Pearce
Canaccord Genuity - Nominated Adviser and Sole Broker +44 (0) 20 7523 8000
Adam James / Harry Pardoe
About Itaconix
Itaconix uses its proprietary plant-based polymer technology platform to
produce and sell specialty ingredients that improve the safety, performance,
and sustainability of consumer products. The Company's current ingredients are
enabling and leading new generations of cost-effective, decarbonized consumer
products in home and personal care.
www.itaconix.com (http://www.itaconix.com/)
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END FURAIMFTMTABBTF
Copyright 2019 Regulatory News Service, all rights reserved